CONTRADICTIONS AND OPPORTUNITIES IN MOBILE CARE MANAGEMENT (“mCare”): AN OBSERVATIONAL ANALYTIC COHORT STUDY by Crowley, Patrick Kenyon
ABSTRACT 
Title of Dissertation: CONTRADICTIONS AND 
OPPORTUNITIES IN MOBILE CARE 
MANAGEMENT (“mCare”): AN 
OBSERVATIONAL ANALYTIC COHORT 
STUDY 
Patrick Kenyon Crowley  
Doctor of Philosophy in Information Studies 
2019 
Dissertation directed by: Beth St. Jean, Associate Professor 
College of Information Studies 
Chronic diseases such as diabetes are among the most widespread, expensive, 
and preventable of all health problems, accounting for approximately 86 percent of 
the United States’ $2.7 trillion annual health care expenditures. In the face of such 
staggering numbers, it is surprising that our current approach to chronic disease care 
management has remained largely unchanged for decades, where the care team 
evaluates the patient and related data infrequently and episodically.  However, mobile 
care management (mCare) information system use is growing, whereby individuals 
with chronic medical conditions such as diabetes are taught to monitor and manage 
their disease through the use of a mobile application for tracking, education and 
feedback, along with monitoring of vital signs with “connected” medical devices, and 
the support of a remote health coach.  These mCare systems offer promise, but many 
unanswered questions exist surrounding their effects on the health and healthcare of 
the users, and how user individual differences may influence these effects. 
Informed primarily by the mobile health systems and health behavior 
literatures, this study provided a deeper understanding of the effects of an mCare 
platform on health outcomes and health services utilization of chronic disease 
patients, principally those with diabetes mellitus, and the effects of a user’s social 
support on these outcomes.  This study analyzed administrative claims, device 
readings, app usage, demographic and social determinant data of 163 diabetic mCare 
users from a 21-week observation period from mCare initiation, along with a well-
matched control group of diabetic non-users, and a supplemental cohort of 127 non-
diabetic mCare users with other chronic medical conditions. 
mCare had a significant positive effect on users’ adherence to physician’s 
office visits, suggesting greater continuity of care, chronic care management, and a 
possible reduction in inpatient use (1.2 fewer encounters over 5 months, on average). 
The findings show that mCare had a significant beneficial effect, on average, 
towards the cardiovascular health of the users as measured by the change in their 
diastolic blood pressure (- 2.8 mmHg, - 3.3%) and systolic blood pressure (- 6.7 
mmHg, - 4.9%) in the five-month observational period, which is a primary 
therapeutic target for diabetes care and clinically important. Furthermore, linear 
mixed models of cardiovascular outcomes uncovered how those mCare users with a 
moderate degree of social support are likely to achieve greater benefit in from mCare 
on average relative to those with very high or very low social support in their lives. 
This additional impact equated to on average a 2.4 mmHg drop (2.9%) in diastolic 
blood pressure and a 3.9 mmHg (3.1%) drop in systolic blood pressure over the five-
month observational period, which is clinically significant. These results provide 
evidence to support a more precisely tailored future healthcare paradigm beyond the 
current one-size-fits-all archetype. 
A primary goal of mCare is triaging emergency department use where 
appropriate; however, this study found that this did not happen in a significant 
manner in the treatment group compared to the control group. Furthermore, the study 
identified specific medical problems where improved mCare design is needed, 
including processes to prevent hyperglycemia, hypoglycemia and exacerbations of 
hypertension and pulmonary issues (such as asthma and chronic obstructive 
pulmonary disease), and a need to assess pain more effectively to foster more 
appropriate healthcare utilization.  
Additional training for health coaches, as well as training and development of 
machine intelligence algorithms to better triage patient problems to appropriate sites 
of care, are productive directions for future research. mCare designers should seek to 
better gauge the severity of pain, and develop new sensor technologies to assess 
emergent issues, especially abdominal pain. mCare vendors should also seek to refine 
their processes to better manage glucose and respiratory issues to avoid 
exacerbations, and predict exacerbations earlier to intervene. 
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Chapter 1: Introduction 
1a. Background of the Problem 
Chronic diseases are among the most widespread, expensive, and preventable 
of all health problems, accounting for about 86 percent of the United States’ $2.7 
trillion annual health care expenditures (Gerteis et al., 2014).  The largest contributing 
factor to death and disability in the United States and across most of the world is 
behavioral choices (Institute for Metrics and Health Evaluation, 2015), as visualized 
in Figure 1 (next page).  More than genetics and more than infectious disease, it is 
humans’ everyday choices about activities like what to eat, how much physical 
activity to do, smoking, sleeping well, managing stress and adhering to medication 
regimens that determine our fate (McGinnis, Williams-Russo, & Knickman, 2002). 
Figure 1 shows the % of disability-adjusted life years (DALYs) associated with our 
behaviors and where these behaviors manifest as medical conditions (IHMS, 2017); 
the number of DALYs associated with a behavior (e.g. smoking), is the estimated 
number of years lost due to ill-health, disability or early death due to that behavior 
(Rushby, 2001).  Billions of dollars of preventable costs and millions of preventable 
disability years are wrapped up in our behavioral choices (Center for Disease Control 
and Prevention, 2016). 
In response to the monumental societal, personal and economic costs of 




Brindle, & Bagenal, 2018) .  Digital health includes categories such as mobile health 
(mHealth), health information technology (IT), wearable devices, telehealth and 
telemedicine, and personalized medicine (FDA, 2019).  The use of technologies such 
as smart phones, social networks and internet applications is changing the ways in 
which we engage with our health and care teams (Fiordelli, Diviani, & Schulz, 2013; 
Mileski, Kruse, Catalani, & Haderer, 2017). 
Novel approaches to monitor our health and well-being offer improved access 
to information and support (Serbanati, Ricci, Mercurio, & Vasilateanu, 2011).  In 
particular, mHealth, which is the use of mobile and wireless applications for 
healthcare purposes (HIMSS, 2019), is leveraging that ever constant companion, our 
smartphone, to change how healthcare traditionally has operated.   





The adoption and use of these tools may offer promise, but to-date efficacy is 
mixed and there are many unanswered questions about the effects of these tools (De 
Geest et al., 2017; Hamine, Gerth-Guyette, Faulx, Green, & Ginsburg, 2015; Kitsiou, 
Paré, Jaana, & Gerber, 2017), some of which may be unintended (Maar et al., 2017) 
and potentially detrimental (Harrison, Koppel, & Bar-Lev, 2007). Critical issues exist 
about how the unique demographic, social determinant, medical and behavioral 
factors may impact the success or failure of digital therapies for those at-risk-of or 
living with chronic diseases (Hamine, Gerth-Guyette, Faulx, Green, & Ginsburg, 
2015). 
The current opportunity is particularly striking because the detrimental effects 
of diabetes and other so-called lifestyle diseases can be mitigated and even in some 
cases, reversed, through better disease management and self-care practices (R. Taylor, 
2013) . This dissertation examines the effects of a particular mobile health 
intervention, mobile care management (“mCare”). In a typical mCare program, a care 
manager connects remotely with patients in need of medical condition improvement, 
provides disease management support and adjusts care using data streams generated 
via a patient’s use of a smartphone or tablet application that includes features for 
delivering targeted education, tracking biometrics through connected devices (e.g. 
Bluetooth-enabled blood pressure cuff), and supporting communication between the 





1b. Research Agenda 
This dissertation seeks to contribute to the mobile health information systems 
literature regarding chronic care management strategies and tools. The findings will 
provide a deeper understanding of the outcomes of Medicaid mCare users’ outcomes 
following mCare use.  Theoretical underpinning is provided by the health information 
systems, health behavior and healthcare utilization literatures.  
The study is important for several reasons.  For one, there can be stark 
differences in how individuals respond to medical therapies.  It is critical to 
understand how mCare may be impacting healthcare and economic outcomes for 
chronic disease patients when used as part of therapeutic regimen for diabetes, one of 
the most costly and prevalent chronic diseases. This study will quantify this through 
comparing a treatment and control group matched sample, a pre-post mCare use 
examination of outcomes, and a linear mixed effects models (to be described in detail 
in the Methods chapter). 
Second, there is increasing credence regarding the role that an individual’s 
social determinants of health play in predicting the health outcomes of individuals 
and populations (Marmot & Allen, 2014), yet the linking of one’s social situation (a 
prominent social determinant) to the impact of mCare in chronic disease populations 
is not well-quantified (Marmot, Friel, Bell, Houweling, & Taylor, 2008).  This 
dissertation helps to fill this void by measuring the interaction of social barriers (e.g. 
not having friends or family to provide support, experiencing social isolation) on the 




Third, by developing a greater understanding of the role of individual 
differences in moderating the effectiveness of mCare, policymakers can enact more 
efficient population health planning, in which resources and intervention choices can 
be directed towards those that are at risk, with the intervention choice that is likely to 
succeed for a target audience member, given choices of health intervention strategies. 
Fourth, adapting digital health therapies for chronic disease is showing 
emerging signs of being a feasible strategy to improve chronic disease management 
(Kitsiou et al., 2017); however, more understanding is needed to understand the 
differences that may facilitate appropriate adaptation in diverse populations (Stowell 
et al., 2018).  This dissertation will integrate and apply social determinants risk data, 
healthcare utilization data, medical condition data, medical device data, and mobile 
application data longitudinally to shed light on the use of mCare for diabetes. These 
data provide real-world evidence.  Furthermore, this dissertation’s analysis and 
insights from high-volume, high-frequency ecological observations may help 
generate future testable theories and facilitate comparisons of information systems in 
the care management domain.  The specific research questions this research aims to 
address include the following: 
RQ1:  What types of health benefits does mCare provide to insurance 
plan members with type 2 diabetes? 
RQ2:  What types of utilization and cost implications does mCare have 




RQ3:  How is the response to mCare of insurance plan members with 
chronic disease related to their demographics and social support? 
A thorough set of methods and data have been used to answer these questions.  
The existing literature providing a foundation for this dissertation study are discussed 
next, followed by a description of the methods and data used to answer the research 
questions. The results are then reported, followed by a discussion of the findings in 
the context of the current healthcare system, along with the conclusions of the study 
including the implications for mCare practice, theory and design.  Finally, limitations 







Chapter 2. Review of the Literature 
Prior work relating to mobile health interventions, healthcare behavior theory, 
and utilization of healthcare, inform the conceptual territory and provide a theoretical 
grounding for this study. 
2a. Mobile Health Interventions 
mHealth (a common abbreviation for mobile health) is defined as mobile-
based or mobile-enhanced solutions that deliver health (HIMSS, 2019). The ubiquity 
of mobile devices across all corners of the world presents the opportunity to improve 
health outcomes though innovative applications of data, devices and interactions. 
mHealth may include a wide array of sensors, connected devices like Bluetooth-
enabled scales and glucose meters, and SMS-messaging and software applications 
that work on one’s mobile smartphone.  These tools, when designed well, may help 
patients manage chronic conditions outside of traditional healthcare settings 
(Garabedian, Ross-Degnan, & Wharam, 2015; Mileski et al., 2017). They can also 
provide value to healthcare providers and payers by facilitating disease prevention, 
diagnosis, and treatment (Hamine, Gerth-Guyette, Faulx, Green, & Ginsburg, 2015). 
Much of the early work (de Jongh, Gurol-Urganci, Vodopivec-Jamsek, Car, & 
Atun, 2012; Fiordelli et al., 2013; Källander et al., 2013) in mHealth focused on 
providing health education and services in low-resource global environments. Recent 
work (Fu, McMahon, Gross, Adam, & Wyman, 2017; Inbal Nahum-Shani et al. 2016; 




& Hussain, 2016) is increasingly focused on using more sophisticated interventions 
that integrate mobile apps, cloud computing and connected sensors.  mHealth 
consumer applications like fitness and nutrition tracking are expanding rapidly, both 
in terms of the number of users and the number of apps  (Bardus, van Beurden, 
Smith, & Abraham, 2016).  In contrast, the uptake of mHealth apps into healthcare 
management practices has been sluggish (Baniasadi, Niakan Kalhori, Ayyoubzadeh, 
Zakerabasali, & Pourmohamadkhan, 2018; Glick, Druss, Pina, Lally, & Conde, 2016; 
Peng et al., 2016). 
Some of the core benefits of mHealth are assisting patients in understanding 
their health condition(s) (De Geest et al., 2017), promoting beneficial behaviors 
(Baron, McBain, & Newman, 2012), and fostering communication with trusted 
resources (De Geest et al., 2017).  Table 1 reports several barriers patients face in 






Table 1. Benefits of mHealth for chronic care  
(Hamine et al., 2015; Hou et al., 2018; Quinn et al., 2011) 
 
There is a growing body of scientific evidence that suggests mHealth can 
facilitate lifestyle behavior change and slow the progression of preventable chronic 
disease (Hou et al., 2018).  Mobile messaging in particular has been demonstrated to 
be effective for use cases including reducing cardiometabolic risk factors (Chow et 
al., 2015), increasing appointment attendance (Gurol-Urganci, 2013), improving 
diabetes self-care (Ferrer-Roca, Cárdenas, Diaz-Cardama, & Pulido, 2004), 
improving medication adherence (De Geest et al., 2017), motivating physical activity 
(Hall, Cole-Lewis, & Bernhardt, 2015), and encouraging users to quit smoking in the 
short-term (Ybarra, Bosi, Korchmaros, & Emri, 2012). Randomized controlled trials 
Patient Barriers to Good Diabetes Outcomes Benefits of  mHealth Features 
Limited feedback and positive reinforcement 
of healthy behaviors 
Automated feedback and positive 
reinforcing messages encourage 
beneficial behaviors. 
Poor insight into health condition and lots of 
information to process 
Increased relevant education delivery and 
micro-learning modules prevent 
overwhelming amounts of information. 
Limited communication with the treatment 
team between office visits and lack of 
evaluation of self-collected diabetes data (e.g. 
capillary glucose, food intake, activity, 
medication adherence) 
Tailored feedback for diabetes data and 
communicating actions to manage 
glucose may decrease risk of adverse 
events. 
Transportation barriers, traffic congestion, 
limited parking for attending physical clinic 
visits 
Reduced need for frequent visits and 
travel allows more patients to get the 
information they require. 
Limited financial or healthcare resources to 
cover office visit copays, medications, and 
self-testing supplies 
Reduced need for office visits may reduce 
costs for patients (e.g. copays). 
Lack of self-motivation to improve health Motivational messaging tailored to 
individual differences increases content 
alignment with patient needs. 
Competing demands on patient time (e.g. 
work, school, family) 
Therapeutic support at convenient times 
and places can yield more likely 




(RCTs) of mHealth interventions targeting diabetes have revealed benefits in quality, 
cost, and patient-centered outcomes (Marcolino et al., 2018; Quinn et al., 2011).  
However, while promising evidence exists about the benefits of mHealth for diabetes 
and other chronic conditions, the outcomes of mHealth interventions can be highly 
varied (Cajita, Gleason, & Han, 2015; Hamine et al., 2015; Marcolino et al., 2018).  
Experts have called for more pragmatic assessments of mHealth interventions 
(Collins & Riley, 2016). 
A recent systematic review (Marcolino et al., 2018) concluded mHealth 
systems show benefits for chronic disease management, reducing deaths and 
hospitalization, and improving quality of life, but more research is needed to unpack 
the drives and differences across subgroups.  An example of the types of individual 
factors that may affect the degree to which users benefit from mHealth include their 
psychological traits (Dugas, Crowley, et al., 2018), amount of social influence 
(Hoque & Sorwar, 2017), disease severity (Georgsson & Staggers, 2016), goal types 
(Adams et al., 2017), and health literacy status (De Geest et al., 2017). 
Chronic disease mobile applications (“apps”) are not new.  Across the App 
Store and Google Play, there are hundreds of apps related to diabetes, for example. 
However, chronic disease apps have a mixed record for effectiveness (Marcolino et 
al., 2018). Programs with components such as goal-setting and self-monitoring that 
use multiple modes of communication with tailored messages were found to be more 




Messages that are simple, brief and personalized have been reported to be the 
most effective for engaging users (Schmid, Rivers, Latimer, & Salovey, 2008).  Even 
though personalization has been shown to increase engagement (Schmid et al., 2008), 
most existing mHealth communication strategies use a “one-size-fits-all” approach 
(Bardus et al., 2016). Personalization can meet the patient attributes that vary such as 
information needs, goals, challenges, and symptoms, etc. (Anderson, Burford, & 
Emmerton, 2016). Therefore not adapting to the significant heterogeneity across 
patients is a missed opportunity to increase efficacy through more relevant, salient 
and useful user interactions (Nahum-Shani, Hekler, & Spruijt-Metz, 2015).  
Evidence suggests there is a considerable opportunity to improve outcomes 
and lower costs for many at-risk patients, such as those with diabetes who struggle 
with the complexities of blood sugar regulation (Cui, Wu, Mao, Wang, & Nie, 2016), 
or congestive heart failure patients who require motivation and reinforcement of 
behavior and medication management (Chen et al., 2016). 
Jimison et al.’s (2008) seminal review of the barriers and drivers to the use of 
interactive consumer health information technology (IT) found that health IT systems 
tended to have a positive effect when the systems provided a complete feedback loop 
that included: (a) monitoring of current patient status, (b) interpretation of this data in 
light of established, often individualized, treatment goals, (c) adjustment of the 
management plan as needed, (d) communication back to the patient with tailored 




Systems that offered only one or a subset of these functions were less dependably 
effective. 
A recent integrative review critiqued the interventions that support diabetes 
self-management (Carpenter, DiChiacchio, & Barker, 2019). The predominant 
interventions for diabetes include: technology-based interventions, patient education, 
motivational interviewing, problem solving therapy, lifestyle modification programs, 
mindfulness, and cognitive behavioral therapy.  These interventions principally 
targeted reductions in glucose as measured by HbA1c, and recorded mixed results, 
that were typically at six months to one year in duration. The lifestyle modification 
interventions targeted diet, exercise, medication management, and behavior 
modification most often, and recorded changes in outcomes such as: diet; physical 
activity; self-efficacy; and stress. The most frequently used intervention was 
technology-based interventions, with telehealth the foremost mode of technology. 
Health coaches, both peer and professional, have been a frequent intervention 
strategy. Professional health coaches frequently employ motivational interviewing, 
which seeks to help patients change their ambivalence to changing behaviors 
(Hibbard, 2016).  These interventions are frequently multi-modal, meaning they 
include multiple components (e.g. coaching plus telehealth plus problem solving 
therapy).  The extensive review concluded that while the diabetes interventional 
research is vast, the translation to clinical utility remains mixed, and there is a need to 




The health coaching used to help patients with diabetes better manage their 
disease traditionally encompasses five main roles, including: (1) providing self- 
management support, (2) bridging the gap between clinician and patient, (3) helping 
patients navigate the health care system, (4) offering emotional support, and (5) 
providing continuity of care (Bennett, Coleman, Parry, Bodenheimer, & Chen, 2010). 
While health coaches have always had to interpret information and decide 
engagement strategies, with the introduction of mHealth tools, an effective health 
coach must be able to interpret more frequent, voluminous and diverse data, in effect 
becoming a data analyst in addition to a behavior change agent. Health coaches must 
decide: who needs attention; the priority of outreaches; what mode of contact may 
work best; and what approach may be appropriate (Kivelä, Elo, Kyngäs, & 
Kääriäinen, 2014). Traditionally, these decisions and tasks were accomplished with 
judgments based on limited data.  Prior work has shown that a primary benefit of 
health coaching for diabetes is helping patients reframe their perceptions of disease, 
including its manageability (Wolever et al., 2010). Virtual coaching eases access to 
support services, reduces patient travel time, and provides timely feedback 
(Ramchandani, 2019). Existing health coaching interventions for diabetes are 
represented by companies such as Omada Health, Virta, Vida, Vheda Health, Noom, 
and many insurance companies operate their own health coaching services. 
The current state-of-the art in diabetes management is centered around 
building a more reliably predictive set of technologies that tailor not only to the 




focus of emerging diabetes health interventions on a more dynamic health behavior 
model leverages existing theory that health behavior is a function of physiological 
and psychosocial state (Glanz & Bishop, 2010), but advances our interpretation and 
practice of interventions by applying a dynamic adaptation (Nahum-Shani et al., 
2015). In diabetes care, the use of continuous glucose monitoring (CGM) can now 
provide a near constant stream of blood sugar values. A new product, the Freestyle 
Libre, released by Abbott, now offers an option to scan one’s blood sugar using a 
wearable sensor on the upper arm, rather than the traditional finger prick glucose 
monitoring method. This advance to reduce the level of effort and pain in ascertaining 
one’s glucose level, should further enhance the ability of diabetes patients to self-
manage.  There is the Eversense sensor, which is an implant that will monitor blood 
sugar every 5 minutes for 90 days after being implanted. The consequences and 
impacts of these new interventions are unknown, but they will likely become more 
mainstream and integrated into managed care programs, mCare and traditional, in 
coming years. 
Other gaps in understanding around the effectiveness of mHealth 
interventions comes from the lack of representation of people of low-socioeconomic 
status in mHealth studies (Stowell et al., 2018).  More comprehensive information 
about the nuances of users and processes for achieving value from these systems is 
needed in order to yield better and more user-centered design of mHealth tools 




used in mHealth, with mixed results.  There is expansive room for future innovation. 
Future innovation should be driven by theory and empirical evidence.   
Next health behavior theories are discussed and their relevance to this 
dissertation study. 
2b. The Complex Landscape of Health Behavior  
Various health behavior theories have been used to support mHealth 
interventions, although reviews have criticized the lack of theory in most mobile 
interventions (De Geest et al., 2017). Additionally, senior leaders at the National 
Institutes of Health (NIH) have asserted that current health behavior theories need 
updating for the mHealth age (Riley et al., 2011). The theoretical basis for mHealth 
interventions can be found in Ecological Momentary Interventions (Free et al., 2013; 
Moskowitz & Young, 2006), the Theory of Self-Efficacy (Albert Bandura, 1977), and 
the Transtheoretical Model of Change (Glanz, Rimer, & Viswanath, 2015).   
Ecological Momentary Interventions are treatments that are delivered to 
people in their everyday lives and in natural settings (Moskowitz & Young, 2006).  
The theory of Ecological Momentary Interventions has strong rationale and a basis in 
psychotherapy, where clinicians have long encouraged patients to practice skills, do 
activities, and complete tasks between therapy appointments (Heron & Smyth, 2010). 
Activities between appointments act as a way to practice, generalize, and maintain 




extended to include health behavior and psychosocial interventions (Heron & Smyth, 
2010).   
A timelier assessment of relevant patient information and responsiveness to it 
for patient care is believed to confer advantages over traditional interventions 
(Burner, Menchine, Kubicek, Robles, & Arora, 2014) . A more ideal mHealth system 
will nudge the user taking into account user state attributes (e.g. mood, vital signs) 
when needed, and conversely, the system can avoid prompting users to do a certain 
behavior when the behavior likelihood is low (Adams et al., 2017; Inbal Nahum-
Shani et al., 2016).  This interaction style facilitates more efficient allocation of a 
user’s resources (Nahum-Shani et al., 2015). The design/architecture of more and 
more modern mHealth tools can facilitate more frequent, dynamic and customized 
feedback loops than have been traditionally applied in health behavior interventions 
(Nahum-Shani, et al., 2016). This enhanced customization using real-time data 
streams extends the capabilities of current interventions to more quickly respond and 
is hypothesized to increase relevance and perceived usefulness of the intervention 
(Nahum-Shani et al., 2015; Schmid et al., 2008). The process of dynamically 
communicating with patients and health coaches is being operationalized currently; 
for example, health coaches and patients may receive real-time alerts when any care 
gaps exist that need attention, such as a very high blood sugar reading or not 
conducting a device reading (De Geest et al., 2017). 
Clinician participation is a frequent component to mHealth, and this social 




with healthcare providers has been shown to significantly affect behavior and 
practices of individuals (van Dam et al., 2005). Researchers have found significantly 
improved adherence as a result of clinician engagement (Cutrona et al., 2010).  
Individual motivation arising from clinician engagement can be very useful to help 
patients overcome perceived barriers to healthy behaviors and treatment adherence. 
However, many studies using telemedicine technology find only moderate 
improvement in outcomes like glycemic control and little effect on costs (Free et al., 
2013). Reviews (Hamine et al., 2015; Marcolino et al., 2018) have concluded that 
more holistic design is needed for interventions, which more fully takes into account 
the differences between users, such as their sociodemographics (Free et al., 2013), 
psychosocial factors (Dugas et al., 2018) and unique goals (Adams et al., 2017). 
The term “health behavior” typically means any behavior that may affect an 
individual’s health (physical or mental), or any behavior that an individual believes 
may affect their health (Sutton, 2004).  Behavior is a complex set of processes 
involving interactions between temperament, personality, cognition, emotion and the 
environment (Horwath, 1999; Sheldon, Jose, Kashdan, & Jarden, 2015).  Health 
behavior change models aim to identify and measure the factors that best predict 
health behaviors (Glanz et al., 2015).  The science behind one’s health decisions is a 
richly studied area, but sadly the field continues to inadequately explain the mysteries 
of human health behavior. 
Changing behaviors is hard and maintaining a new behavior even harder 




several prominent theories (Glanz et al., 2015) that help explain the structural and 
psychological determinants of behavior.  Traditional health behavior models typically 
posit that individual differences, such as demographics, personality, education, 
beliefs, feelings and health status are predictive of behaviors (Glanz et al., 2015).   
The Health Belief Model (one of the health behavior domain’s oldest and 
most commonly used models), for example, conceptualizes an individual’s likelihood 
of taking a health-related action (i.e., changing their diet), as resulting from four 
primary factors, including one’s perceived susceptibility to disease, perceived 
severity of the disease, perceived benefits of the health promoting behavior, and their 
perceived barriers to successfully doing the behavior (Rosenstock, 2000).   However, 
the Health Belief Model and most behavior change models generally fail to 
effectively explain how much the underlying factors influencing health predict health 
behavior outcomes, and these model factors are not very instructive for behavior 
change intervention designers (C. J. Carpenter, 2010; Glanz & Bishop, 2010). The 
majority of behavior change interventions based on the Health Belief Model have 
been shown to have modest predictive ability of actual health behaviors (Bilic, 2005; 
Wootton, 2012). 
Stage-based health behavior change models have been popular frameworks, as 
well (Prochaska & Velicer, 1997; D. Taylor et al., 2006; Wilson, 1999). The most 
widely used stage model has been the Transtheoretical Model (TTM, also called 
Stages of Change), which posits (as virtually all stage-based models of behavior 




(Glanz et al., 2015; Prochaska & DiClemente, 1982).  The TTM indicates there are 5 
to 6 stages, which may be repeated when regression or relapse occurs. These stages 
typically include: precontemplation, contemplation, preparation, action, maintenance, 
and termination. Some external factors have a stronger effect during specific stages. 
For example, social support is especially beneficial during the preparation, action, and 
maintenance stages (Horwath, 1999). Studies evaluating the TTM have shown that 
stages can be a useful approach to modeling human behavioral processes, albeit 
stage-based interventions have shown mixed efficacy (Johnson et al., 2008). The 
periodic and discrete nature of the stages is insufficient to fully capture human 
behavioral processes, as real-world behaviors are diverse and non-linear (Glanz & 
Bishop, 2010; Glanz et al., 2015). 
More recent stage-based models have been proposed, such as Li and 
colleagues’ stage model of personal informatics (Li, Dey, & Forlizzi, 2010), which 
was designed to model information behaviors among users of personal informatics 
systems, those systems that help individuals to track, monitor and understand their 
health information (Li et al., 2010).  The five stages in Li’s model include preparation 
(reasons for collecting data), collection (recording data), integration (how data are 
combined, augmented, and transformed), reflection (how a person makes sense of 
data), and action (whether a person acts on the data).  Researchers have found that 
personal informatics systems can create problems at specific stages (Kim et al., 
2016). For example, individuals who rely on activity tracking tools (e.g., FitBit) may 




limited access to raw data stored in proprietary systems. The use of mobile health 
systems, such as those which integrate expert help and decision-support for 
translating personal data into actionable disease guidance, has promise to overcome 
the limitations of individuals to understand and act on their personal health 
information. This type of mobile health system is being studied in this dissertation (to 
be discussed further in the Methodology chapter). 
An individual’s physical and mental states fluctuate regularly, in personally 
unique ways, moderated by one’s attitudes, beliefs, and characteristics. Some 
individual states change near continuously (such a synapse firings), while others are 
more stable and constant (such as one’s degree of neuroticism or age).  An 
individual’s state can influence his/her predicted likelihood of behavior change at any 
given point in time (Nahum-Shani et al., 2015). But unfortunately, current behavioral 
intervention designs do not generally incorporate functions to adjust to fluctuating 
states. 
A key aspect predictive of one’s behavioral outcome has been shown to be 
their level of motivation to achieve the given outcome (Ryan & Deci, 2000). 
Individuals are more motivated when they perceive themselves to be competent 
(Ryan & Deci, 2000). This concept is central to mCare platforms, which aim to 
enhance self-efficacy. Self-efficacy is concerned with people's beliefs in their ability 
to influence events that affect their lives (Bandura, 1986). Self-efficacy is the 
fundamental construct within Bandura’s social cognitive theory (SCT), which 




1986).  The second core SCT construct is outcome expectations, which indicate one's 
judgments of the likely consequences of doing, or not doing, a particular behavior.  
Goals are the third construct, involving self-monitoring, specific goal-setting and self-
reward.  The use of mobile health systems, including mCare, may work because of 
their ability to increase perceptions of self-efficacy, goal setting and a better 
understanding of the potential outcomes from the use of these systems (Jimison et al., 
2008). 
Existing behavior change models suffer from two major limitations.  Existing 
models do not adequately account for the near continuous changes in human’s mental 
(e.g. depressed, motivated) and physical state (e.g. fatigue, rested) or context (e.g. 
with healthy or unhealthy peers).  Rather, current models are general instruments, 
providing limited utility in guiding intervention strategies for behaviors moderated by 
frequent state changes, which are most behaviors.  A second major limitation of 
behavior change models is related to translating models into interventions.  The use of 
theory in intervention design and implementation fidelity to theory are generally poor 
(Abraham & Michie, 2008).  For example, while existing models have identified the 
importance of tailoring interventions based on users’ individual differences, the actual 
adaptation of interventions based on these differences is very limited (Marcolino et 
al., 2018).  
Further, while many researchers have found evidence of the role of individual 
differences in moderating health behavior change efforts, historical applications of 




2018).  A more precisely tailored and temporally rich behavioral intervention design, 
such as well-designed mCare offers, may improve adoption and efficacious use. 
A variety of factors influence one’s ability to self-manage a chronic disease. 
One’s social-economic context, i.e. “the conditions in which people are born, grow, 
live, work and age” (World Health Organization, 2011, p. 10) has received significant 
attention in recent years (Braveman & Gottlieb, 2014, pg 19) . These “social 
determinants” of health, include factors like socioeconomic status, education, 
neighborhood and physical environment, employment, and social support networks, 
as well as access to health care (Beddoe, 2012).  At present in the United States 
healthcare market, healthcare provider and payer organizations are starting to test out 
the prescribing of social determinant solutions like healthy food and transportation 
(Weintraub, 2019). For diabetic patients, a systematic review identified that it was the 
patient’s financial resources, co-morbidities, and social support that are the key 
influential factors impacting better diabetes self-management. (Nam, Chesla, Stotts, 
Kroon, & Janson, 2011). 
Social relationships in particular have been shown to influence broad aspects 
of one’s health and attitudes, and to be predictive of clinical outcomes (Christakis & 
Fowler, 2007). Chronically ill patients also frequently report barriers such as 
depression, weight problems, difficulty exercising, fatigue, poor physician 
communication, pain, and financial problems, but these problems vary in intensity 
across a patient population (Jerant, Von Friederichs-Fitzwater, & Moore, 2005).  It is 




influential barriers at the individual patient level and the health interventions that may 
be most effective for a particular patient at a specific point in time along their disease 
management journey. 
While there is considerable prior health behavior theory (Glanz et al., 2015), 
the complexity of the human condition rarely fits neatly in health behavior change 
frameworks, and real-world evidence and trials of new digital health interventions are 
needed to achieve more consistent and greater beneficial impacts on chronic disease.  
A brief discourse on health services utilization is provided next. 
2c. Health Services Utilization 
The use of mCare has largely been advocated for based on the presumption 
that it can have a positive effect on the utilization of health care services. In 
particular, it is believed that its use may reduce unnecessary and expensive 
emergency department (“ED”) use, and result in better use of office visits and 
primacy care (LaCalle & Rabin, 2010).  ED use is of keen interest because of 
evidence of rising ED visit rates per capita, the expense of hospital-based emergency 
care relative to primary medical care, and ED use being considered a frequent proxy 
for inaccessible or low-quality outpatient care (Van den Heede & Van de Voorde, 
2016). 
Economic theory indicates that increasing access to health services, vis a vis 
insurance or other access mechanisms (e.g. mCare), could either reduce or increase 




is decreased significantly when they have health insurance (to their co-pay amount), 
which may lead to more frequent visits. However, if the ED has been used in place of 
outpatient care by the uninsured, then health insurance coverage may transfer care to 
office locations and reduce ED visits.  The Oregon Health Insurance Experiment, a 
randomized trial of Medicaid coverage in Oregon conducted from 2008 to 2010, 
established that Medicaid coverage was linked to a 40% increase in ED use 
(Finkelstein, Taubman, Allen, Wright, & Baicker, 2016).  However, other studies 
have shown that Medicaid coverage may reduce ED visits, such as when Tennessee 
removed nearly 170,000 adults from Medicaid and discovered that ED visit rates 
increased (Sommers, Blendon, Orav, & Epstein, 2016).  These contradictory findings 
suggest there is more to the story.   
Having access to healthcare through insurance is one factor in driving possible 
health services use. An additional possible influencer of health services use due to 
having insurance is that plan members receive information about their health and 
available healthcare services. This change to a health plan member’s information 
environment may result in their greater consumption of this information. Health plan 
communications frequently promote wellness activities.  Related to the consumption 
of health services is consumption of health information (Rosenstock, 2005).  Several 
studies have shown that large numbers of healthcare consumers prefer to actively 
avoid information about their medical condition (Case, Andrews, Johnson, & Allard, 
2005; Wong et al., 2000).  Among diabetics in particular, these individuals were 




people developing diabetes-related problems (St. Jean, 2012) .  In the context of 
mCare, a health coach is making the potential impacts of a disease more salient and 
understandable to patients and sharing the coach’s experiences of working with other 
diabetics and what happened with those patients, so it may not be surprising if 
patients are more motivated to use health services and utilization increases.  Making 
the disease proximate to individuals and thereby activating them is a well-known 
strategy of interventions and health behavior change theories (Abraham & Michie, 
2008).  Further, many diabetics are unsure where to turn for diabetes-related 
information on their own (Franek, 2013), so health coaching works to guide patients 
to the appropriate care (Hibbard, Mahoney, Stock, & Tusler, 2007), and therefore 
healthcare utilization may increase. 
A recent review article covering the policy interventions aimed to reduce ED 
use (Van den Heede & Van de Voorde, 2016), concluded current evidence on the 
effectiveness of interventions to reduce ED use remains inconclusive. Very little is 
known on the impact of mCare in particular, on ED utilization.  This dissertation 
helps to paint a more vibrant picture of how mCare influences health services 





Chapter 3: Methodology 
 The data used for this dissertation project was constructed from the real-world 
use of an mCare solution covering three health plan customers of an mCare services 
provider located in the eastern United States.  This retrospective secondary dataset 
was approved for use in this study by the University of Maryland Institutional Review 
Board. 
Technology and process being studied - mCare 
This dissertation focuses on a particular type of mHealth intervention, which 
is a mobile care management system, also referred to as “mCare”. mCare is an 
emerging tool to bring care management practices into the connected care and mobile 
age. The typical mCare platform includes multiple connected medical devices, a 
smartphone app, real-time assessment engine and a health coach operations 
dashboard.   
Figure 2 below summarizes the mCare platform operations by its five primary 
steps: (1) Identify care plan through an app-based assessment protocol; (2) Perform 
live coaching through video conference and text via smartphone; (3) Provide 
feedback and monitor compliance with devices/sensors; (4) Identify and resolve care 
issues through real time analytics; and (5) Patient self-management with less frequent 
health coach support. Steps one through four are the “high touch” period, which is 
followed by a “low touch” period in which the patient is no longer meeting weekly 




system about their disease self-management progress and possible issues. The 
approximate weeks of duration of these steps is provided in Figure 2. 
 
 
The process of delivering mCare begins either with the health insurance plan 
or their designee identifying health plan members with problematic health and cost 
outcomes, usually via an analysis of medical claims data.  Selection strategy typically 
entails an educated guess about the members for which the mCare provider can 
successfully improve outcomes.  Member contact is made notifying the member of 
their eligibility, which may be with a letter (typical contact channel), phone call or 
email. Upon the member’s verbal acceptance into the Company’s program, an mCare 
1) Identify care plan through 
an app-based assessmemt 
protocol (first week of use)
2) Perform llive coaching 
through video conference 
and text via smartphone 
(weeks 1- 16)
3) Provide feedback and monitor 
compliance with devices/sensors
(weeks 1- 52)
4) Identify and resolve care 
issues through real time 
analytics
(weeks 1-52)
5) Patient user self-
mgmt "low touch" period 
(weeks 16-52)




kit is shipped to the member. The kit typically includes a smartphone preloaded with 
the Company’s mobile app, and a set of connected devices/ sensors such as a 
glucometer, weight scale, and blood pressure cuff.  There are hundreds of possible 
connected devices that the platform could use. 
A health coach is assigned, who will initiate virtual visits with the member. 
The member completes a series of questions in the mobile app to specify their 
sociodemographic characteristics and disease self-management potential barriers, 
including their social support situation. The program is typically planned for 12 
months with a 4-month “high-touch” period consisting of education, health measure 
monitoring and weekly health coach visits, followed by an 8-month “low-touch” 
period.  The expectation is that the member will have learned how to monitor and 
manage their medical condition during the initial four months. After four months, low 
touch monitoring continues for eight months, with ad-hoc health coach support as 
needed, such as if measures trend negatively or if the health plan member needs help 
triaging an issue like chest pain. 
The observational period for this study is five months, covering the entire high 
touch period through the first month of the low touch period. The study participants 
and treatment and control group assignments are described next. 
Study Cohort 
Figure 3 lists the study population and the decision process for the assignment 
of the treatment and control groups.  There were 1,487 members in the medical 




members with diabetes using the R package Comorbidity (Gasparini, 2019) that 
resulted in 1,064 members with diabetes. Of those 1,064, 409 had begun using mCare 
by June 11, 2018, which was the mCare enrollment cutoff date for this study.  
Figure 3. Treatment and control group selection 
 
 
Of those 409 members, insurance eligibility information was available for 278 
of them, which included their demographic data. Of these 278 members, 269 (96.8%) 
had medical device reading data. The comparison cohort members had to have a 
minimal level of usage to be representative of an mCare user. The 269 members were 
further filtered to include only those that had used a connected device at least two 
times per week on average, logged into the mobile app at least two times per week on 




observational period. This filtering reduced the treatment cohort to 179 members.  
Next, only those members which had insurance coverage during the full 21-week 
observational period were included, which reduced the treatment cohort size to 165 
members.  Finally, a further screening of diabetic members was performed to remove 
any members that only had one instance of a diabetes ICD code in their claims 
records, as sometimes a single diabetes ICD code may be indicative of just a 
suspected diabetes diagnosis or screening. Using the diabetes codes identified by 
Qwan et al. (2015), this final screening procedure filtered out 2 of the 165 members, 
resulting in a final treatment cohort of 163 members. 
For the creation of a control group (see column B in Figure 3), a similar 
selection approach was used.  Of the 1,064 health plan members identified as having 
diabetes through the R Comorbidity package, there were 655 individuals that were 
not part of the mCare program.  Of these 655, there were 396 plan members that had 
eligibility information including demographics and 21 weeks of continuous insurance 
coverage.  These control group eligible members were screened to only include 
members with at least two diabetes ICD codes, which reduced the control-eligible 
sample to 306 members. A matched sample of 163 members from those eligible was 
generated using the matchit R package for propensity score matching (Ho, Imai, 
King, Stuart, & Whitworth, 2018), which is discussed further under the matching 
procedures section. 
A further 127 non-diabetic mCare users (see column C in Figure 3) are included 




cohort was for experimentation when no significant effects were found among the 
326-member cohort (163 treatment group, 163 control group) of plan members with 
diabetes mellitus.  By adding 127 other chronic disease patients using mCare at the 
same thresholds of use, the analysis sought additional power to detect the influence of 
social determinant factors on the effectiveness of mCare on chronic conditions in 
general. These 127 members had congestive heart failure (CHF) and/or chronic 
obstructive pulmonary disorder (COPD) and were using a similar mCare treatment 
regimen with health coach support, the app, and connected devices including a blood 
pressure monitor and weight scale. 
Matching procedures for the treatment and control group 
The 163-member treatment group was matched with a similarly structured 
163-member control group.  Balanced matching aims to ensure the distribution of the 
matching factors to be the same or nearly the same across groups of individuals 
(Mansournia, Hernán, & Greenland, 2013).  Matching was performed using the 
available disease severity and demographic factors that are predictive of chronic 
disease health outcomes and healthcare use (De Boer, Wijker, & De Haes, 1997).  
These variables included:  age, gender, whether the member has diabetes with 
complications, congestive heart failure (CHF), and the weighted Charlson Index score 
(a comorbidity severity measure). Following the recommendations of Ho et al. 
(2011), propensity score matching was used.  In a perfect experiment, there would be 
exact matching by health insurance plan, however, given the composition of the 




perfect match on plan scenario was found to yield significant variation in clinical 
severity of the matched treatment and control groups; therefore exact matching by 
plan was not favored. Given the inability to exactly match on plan, additional 
robustness checks were conducted that analyzed the variation in results when 
excluding a plan from the sample versus inclusion of all three health plans. 
Table 2 reports the absolute value or mean value of the attributes of the 
treatment and control groups, with the percentage variation.  The table shows that for 
age, gender, and presence of diabetes with complications, the treatment group and 
control group are well-matched. The average weighted Charlson score, which is a 
measure of comorbidity typically ranging from 0 – least severe to 20 - high severity 
(described further in the proceeding section), in the control group is a 0.5 absolute 
difference higher, meaning the control group was slightly sicker than the treatment 
group, on average. 










Cohort size 163 163 0 0.0% 
Age 54.1 54.3 - 0.2 < 1% 
Gender     
    Male 56 59 - 3 - 5.0% 
    Female 107 104 3 2.8 % 
Diabetes w/ complications 99 98 1 1.0 % 
Charlson comorbidity score 5.24 5.75 - 0.5 - 9.7 % 







A combination of clinical, administrative, sociodemographic and mCare 
system use measures were analyzed to develop the findings. Table 3 Measures and 
Sources reports the measures and data sources used for the analysis, followed by 
additional description of these variables. 
 
Table 3. Measures and sources 
 
Measure Construct Variable(s) Data Source 
Cardiovascular health, 
diabetes management 





Systolic blood pressure (mmHg) 
Device reading 
repository 










Demographics Age, gender Insurance eligibility file 
Comorbidity 
Charlson Comorbidity Index, 
presence of medical conditions 




Score of self-reported barriers (0-
100 scale) 
Patient-reported in app 
Device readings Frequency of device usage App’s device log data 
App use Frequency of logins App’s login log data 
Place of service use 
Number and costs of ED, 
physician’s office, Inpatient visits. 
Type of ED visit. 
Claims records (21 
week observation 
period) 
Place of service cost 
Amount spent at sites of care (ED, 
physician’s office, Inpatient) 










To estimate the comorbidity of plan members, the Charlson Comorbidity 
Index (”CCI”) was applied (Charlson, Pompei, Ales, 1987).  CCI is a method of 
predicting mortality by classifying a patient’s comorbid conditions (Charlson ME, 
Pompei P, Ales KL, 1987); this scoring system has been broadly applied by health 
researchers seeking to measure the burden of disease in individuals and populations 
(Quan et al., 2011, 2005), and has been validated for its ability to predict mortality in 
various disease subgroups (Quan et al., 2011).  Each of 17 comorbidity categories 
(cancer, diabetes, congestive heart failure, AIDS …) used in the CCI has an 
associated weight (from 1 least severe to 6 most severe), based on the adjusted risk of 
mortality (i.e. the risk of dying associated with each condition), and the sum of all the 
weights results in a single comorbidity score for a patient (Johnson et al., 2015). The 
members included in this dissertation study ranged from a score of 1 to 22, with a 
mean and median of 5.5 and 5.0, respectively. To compute a score, for example, if 
one has a metastatic solid tumor (weight = 6) and diabetes with end organ damage 
(weight = 2), and no other conditions, this person’s score would be 8. 
The following section further discusses the methods and data used to answer 
each research question. 
RQ1:  What types of health benefits does mCare provide to insurance 
plan members with type 2 diabetes?   
For research question one, a Pre-Post Analytical Design is utilized to compare 




weight, glucose) with their device readings at the end of the 21-week observational 
period.  For the baseline measure, the average of their week one readings are 
computed. For the post-mCare use reading measures, the average of their readings in 
month 5 (weeks 17-21) were used. The difference between these two measurements is 
their change. Mean values at each measurement period (baseline – week 1, month 1, 
month 2, month 3, month 4, month 5), along with 95% confidence intervals, were 
computed and then graphed using ggplot for R (Chang, 2013). 
The primary dependent variable used for the RQ1 analysis was blood pressure 
(both systolic and diastolic), which is a primary indicator of cardiovascular health 
(D’Agostino et al., 2008).  The reason for using blood pressure as the outcome 
variable, rather than hemoglobin A1c (which is a common outcome measure of 
diabetic outcomes), is threefold.  First, patients with diabetes are at high risk of 
developing a major cardiovascular event, such as myocardial infarction or stroke 
(Angermayr, Melchart, & Linde, 2010).  By better managing blood pressure, diabetes 
patients can reduce their risk of medical complications (Angermayr, Melchart, & 
Linde, 2010).  Therefore, a key therapeutic target for physicians caring for diabetes 
patients and for care managers is well-managed blood pressure (Angermayr, 
Melchart, & Linde, 2010).  The National Institutes of Health recommends the optimal 
treatment for a patient with diabetes is to manage the multiple modifiable risk factors 
including blood pressure (NIDDK Health Information Center, 2018). The second 
primary reason for selecting blood pressure is that the use of blood pressure in 




given the importance of blood pressure to diabetic patient health outcomes.  Finally, 
given the data collection parameters of this real-world study, hemoglobin A1c was 
not an available measure. 
In addition to blood pressure, the baseline, monthly average and ending 
measures of health plan members’ weight and glucose are estimated. As previously 
discussed, members are provided with a weight scale that is connected to the cloud 
via a cellular signal. Members are also provided with a glucometer that connects to 
the mCare vendor-provided smartphone via Bluetooth, which then synchs with the 
cloud to upload the glucose data. 
In order to minimize the potential effect of outliers, Winsorization (Ruppert, 
2014) of reading values greater than three standard deviations from the mean reading 
value were trimmed. This Winsorization process was used with the blood pressure, 
weight and glucose reading values.  The trimmed values represented less than 2% of 
device readings. 
RQ2:   What types of utilization and cost implications does mCare have 
for insurance plans and their members with diabetes?   
Analysis was performed to quantify the use and cost of emergency department 
visits, office visits and inpatient stays in the treatment group and control group. 
The administrative claims data used for this study includes the amount 
charged and paid for each member, place of service utilized (e.g. emergency 
department, hospital, physician’s office.), each visit’s ICD10 codes, short textual 




10th revision of the International Statistical Classification of Diseases and Related 
Health Problems, a medical classification list by the World Health Organization 
(World Health Organization, 2016). 
The analysis went a step further and reviewed the most frequent diagnoses 
found in the treatment and control groups in order to evaluate the reasons why they 
used the different treatment sites of interest. The analysis also conducted textual 
analysis of the diagnosis descriptions found in the claims records to help identify 
potential patterns or services within and across the treatment and control groups.  To 
perform this text analysis, NVivo 12 was used to quantify the word frequencies. 
A key area of concern for mCare companies and their insurer customers is 
appropriate ED use and triaging care to the most appropriate and cost-effective site of 
care. For this study’s ED utilization analysis, multiple methods were applied.  First, 
ED visits were identified using their place-of-service code (code = 23).   Then, each 
health plan member’s ED visit was classified into one of four severity categories 
using the New York University ED Algorithm (EDA) (Ballard et al., 2010; Gandhi & 
Sabik, 2014).  The EDA was developed based on expert reviews of information from 
comprehensive medical charts of nearly 6,000 patients, from which each ED visit is 
classified into categories. The ICD9 and ICD10 codes of those reviewed visits were 
analyzed and translated into an algorithm for classifying ED visits. The potential visit 
categories, as defined by the NYU ED algorithm authors (Billings, Parikh, & 




• Non-emergent: The patient's initial complaint, presenting symptoms, vital 
signs, medical history, and age indicated that immediate medical care was 
not required within 12 hours; 
• Emergency care needed: Primary care physician treatable: Based on 
information in the record, treatment was required within 12 hours, but care 
could have been provided effectively and safely in a primary care setting. 
The complaint did not require continuous observation, and no procedures 
were performed or resources used that are not available in a primary care 
setting (e.g., CAT scan or certain lab tests); 
• Emergency care needed - Preventable/Avoidable: Emergency 
department care was required based on the complaint or procedures 
performed/resources used, but the emergent nature of the condition was 
potentially preventable/avoidable if timely and effective ambulatory care 
had been received during the episode of illness (e.g., the flare-ups of 
asthma, diabetes, congestive heart failure, etc.); and 
• Emergency care needed - Not Preventable/Avoidable: Emergency 
department care was required and ambulatory care treatment could not 
have prevented the condition (e.g., trauma, appendicitis, myocardial 
infarction, etc.). 
Figure 4 depicts the flow of classifying the ED visits, observing that mental 
health-related, alcohol-related, substance abuse-related, injury, and unclassifiable are 




Figure 4. NYU ED algorithm diagram (Ballard et al., 2010) 
 
Independent researchers have conducted analysis that supports the validity of 
this algorithm for differentiating ED visits based on need for hospitalization and/or 
mortality risk (Ballard et al., 2010).  The ED algorithm is therefore a useful tool to 
support assessment of interventions and policies aimed at reducing the use of the ED 
for non-emergencies. 
In order to minimize the potential effect of extreme outliers, Winsorization 
(Ruppert, 2014) of values greater than three standard deviations from the mean 
number of encounters by site was used. Winsorization was also applied to the cost of 
paid claims estimates by site, at the three standard deviation mark. 
The treatment and control groups’ utilization for the different visit types were 
compared.  Descriptive statistics, t-tests, and effect size estimates were used to model 
the differences between the treatment and control group. The results were analyzed 




of a health plan. Paired t-tests were used for comparison of matched samples, 
following the recommendations of Austin (2011). 
RQ3: How is the response to mCare of insurance plan members with chronic 
disease related to their demographics and social support? 
Research question 3 seeks to gauge how the social context and demographics 
of an individual with diabetes and/or another type of chronic disease may moderate 
the health outcomes associated with the use of mCare.  To estimate the effects of 
mCare, descriptive statistics, t-tests, effect sizes and linear mixed models were used. 
Linear mixed modeling was applied using the R package lme4 (Bates, Mächler, 
Bolker, & Walker, 2015). 
When an mCare user begins the mCare program, they are served an in-app 
questionnaire asking about their particular barriers. Of particular interest for this 
dissertation study was the degree of social support an individual perceives and their 
access to healthcare. The full questionnaire is considered proprietary to the mCare 
vendor, and therefore is not possible to share. 
In order to assess the possible groupings of the member responses to the in-
app questionnaire into themes related to this study’s research question, the inter-
relatedness of the social support-related questions were evaluated using Cronbach’s 
alpha (ɑ) (Bland & Altman, 1997). Cronbach’s alpha is a measure of internal 
consistency; that is, how closely related a set of items are as a group. Cronbach’s 




support barriers’ combined Cronbach’s alpha is 0.74, which is considered an 
acceptable level for grouping (Taber, 2018). 
Social support barrier questions: 
• I spend most days at home alone: 0 (never) …. 100 (always) 
• I have friends I can rely on and talk to: 0 (whenever I need them) … 100 (not 
reliable) 
• My family gets along:   0 (a lot of the time) ….  100 (rarely) 
• My family talks about everything; both good and bad: 0 (most of the time) …. 
100 (rarely) 
Table 4 reports the mean value of the treatment cohort’s self-reported 
assessments of their social barriers.  
 














Question Mean (sd1) 
My family gets along 22.1  (31.7) 
My family talks about everything; both good and bad 22.6 (33.5) 
I spend most days at home alone 30.6 (33.9) 
I have friends I can rely on and talk to 21.5 (32.6) 




Figure 5 shows the interface similar to the one used to input a response to the 
social support barrier questions. A user has a slider bar that represents the degree of 
social support the respondent perceives with a positive and negative anchor on each 
end of the scale, with a color transition corresponding to positive (green) and negative 
(red). The leftmost side of the scale equates to a zero barrier score and the rightmost 
side as a barrier score of 100; if the respondent marked their social support barrier in 
the middle, that equates to a score of 50, for example. 
 
 
Figure 5. User mobile interface for questionnaire (0 = never, 100 = always) 
 
Table 5 summarizes the methods used to address each of the three primary 
research questions.  Well-designed observational studies have been shown to provide 
results similar to randomized controlled trials (Song & Chung, 2010) , and this set of 






Table 5. Summary of research methods used 
 
Research Question Primary Methods 
 
RQ1:  What types of health benefits does 
mCare provide to insurance plan 
members with type 2 diabetes? 
 
Pre-post measurement of clinical condition 
indicators (blood pressure, glucose, weight) 
of treatment group. Indicators include 
diastolic blood pressure, systolic blood 
pressure, glucose level, and weight. 
 
 
RQ2:  What types of utilization and cost 
implications does mCare have for 




Differences among treatment and control 
group utilization of health services, including 
number of visits and cost of inpatient stays, 
office visits, and ED use.  Frequency of 
specific ICD codes. 
 
 
RQ3:  How is the response to mCare of 
insurance plan members with chronic 
disease related to their demographics and 
social support? 
 
Linear mixed-effects models of clinical 
condition indicators (blood pressure, glucose, 







Chapter 4:  Research Results 
The analysis of these health plan members’ use of mCare yielded several 
interesting findings.  These results are discussed in the proceeding section in the order 
of their corresponding research question. 
RQ1:  What types of health benefits does mCare provide to insurance plan 
members with type 2 diabetes? 
For research question one, a pre-post mCare use analysis of the treatment cohort 
was applied regarding changes in blood pressure, weight and glucose levels.  (Device 
readings are not available for non-mCare users in the control group) 
Diastolic blood pressure: Results revealed a significant decrease in mean 
diastolic blood pressure at observational period end (month 5) versus baseline.  The 
mean diastolic blood pressure at baseline equaled 84.6 mmHg (standard deviation = 
11.28, standard error = 1.73, 95% confidence interval), whereas the mean diastolic 
blood pressure at month 5 equaled 81.8 mmHg (standard deviation = 10.38, standard 
error = 1.59, 95% confidence interval).  On average, members reduced their diastolic 
blood pressure by 2.8 mmHg, which is a 3.3% reduction.  Approximately 85% of 
treatment group members monitored blood pressure during month 5.  About 52% of 
the treatment group who initiated mCare had a ½ mmHg or greater drop in diastolic 
blood pressure over the 5-month observational period. A Welch’s 2-sample t-test 
indicates that there was a significant decrease in diastolic blood pressure (mmHg) at a 




reports the mean value of diastolic blood pressure (mmHg) at monthly intervals, with 
the 95% confidence interval range as whiskers. 
Figure 6. Monthly diastolic blood pressure average value (mmHg) 
 
Systolic blood pressure: Analysis of systolic blood pressure results reported a 
significant decrease in mean systolic blood pressure at observational period end 
versus baseline. The mean systolic blood pressure at baseline equaled 137.5 mmHg 
(standard deviation = 18.7, standard error = 2.86, 95% confidence interval), whereas 
the mean systolic blood pressure at month 5 equaled 130.8 mmHg (standard deviation 
= 17.1, standard error = 2.63, 95% confidence interval).   On average, members 
reduced their systolic blood pressure by 6.7 mmHg, which is a 4.9% reduction.  
Eighty-five percent of treatment group members monitored blood pressure during 
month 5.  Fifty-eight percent of the treatment group who initiated mCare had a ½ 
mmHg or greater drop in systolic blood pressure. A Welch’s 2-sample t-test indicates 
that there was a significant decrease in systolic blood pressure at a 95% confidence 




Figure 7 reports the mean value of systolic blood pressure (mmHg) at monthly 
intervals, with the 95% confidence interval range as whiskers. 
Figure 7. Monthly systolic blood pressure average value (mmHg) 
 
The results reported suggest that the use of mCare can significantly influence 
cardiovascular health targets, as measured by diastolic and systolic blood pressure. 
Table 6 reports the mean absolute and percentage changes in diastolic and systolic 
blood pressure, and shows that on average, members using the mCare system dropped 
their blood pressure, with those members in the 1st quartile of degree of change 






Table 6. Blood pressure at observational period end (mo. 5) versus baseline  
 
 Change in Diastolic BP (mmHg) Change in Systolic BP (mmHg) 
 Absolute 
change 
% change Absolute 
change 
% change 
1st quartile - 7.9 - 9.3% - 13.2 - 9.6% 
Median - 2.9 - 3.4% - 6.7 - 4.9% 
Mean - 2.8* - 3.3% -6.7** - 4.9% 
3rd quartile 1.9 2.2% 2.4 1.7% 
+Significant based on Welch’s two sample t-test (*** p-value < 0.001,  ** < 0.01,  * <0.05) 
 
The analysis also assessed the changes in bodyweight and glucose of the 
treatment cohort; these results follow. 
Weight: The analysis included a comparison of bodyweight across the 
observation period. The bodyweight analysis revealed no significant changes in 
weight at the observational period end versus baseline.  Mean body weight at baseline 
equaled 223.5 lbs. (standard deviation = 55.6, standard error = 8.54, 95% confidence 
interval), whereas the mean body weight at month 5 equaled 224.7 lbs. (standard 
deviation = 56.6, standard error = 8.69, 95% confidence interval).  A Welch’s 2-
sample t-test indicates that there was not a significant change in weight at a 95% 
confidence interval (t = -0.17085, df = 266.36, p-value = 0.8645). 
Figure 8 reports the mean value of body weight at monthly intervals, with the 






Figure 8. Monthly bodyweight average value (lbs.) 
 
Results revealed no significant changes in blood glucose levels at observational 
period end versus baseline.  Mean glucose level at baseline equaled 181.6 mg/Dl 
(standard deviation = 71.5, standard error = 10.98, 95% confidence interval), whereas 
mean blood glucose level at month 5 =  178.4 mg/Dl. (standard deviation = 71.4, 
standard error = 10.96, 95% confidence interval).  A Welch’s 2-sample t-test 
indicates that there was not a significant change in blood glucose levels (mg/Dl) at a 
95% confidence interval (t = 0.23575, df = 103.45, p-value = 0.8141). 
Figure 9 reports the mean blood glucose level at monthly intervals, with the 95% 






Figure 9. Monthly blood glucose average value (mg/dL) 
 
This dissertation study is also concerned with utilization and costs information 
associated with mCare use, which is discussed next. 
RQ2:  What types of utilization and cost implications does mCare have for 
insurance plans and their members with diabetes? 
Research question 2 pertained to outcomes of keen interest to health insurance 
plans, which serve as one of the primary purchasers of mCare systems.  As described 
in the Methodology chapter, two principal measures were evaluated through the 
comparison of the matched control group with the treatment group, including the use 
of care locations (e.g. ED and office visits), and cost of health services as evidenced 
by the amount paid by the insurer.  The most frequent conditions presenting at certain 
sites of care was also evaluated. 
Table 7 reports count of visits to the emergency department (ED) for the 
treatment and control group over the course of the five-month (21 weeks) 




2010), as detailed in the Methods section.  The absolute and percentage differences 
are provided, as well as an effect size estimate.  
Table 7. Emergency department utilization during observational period (treatment vs. 
control group) 
 
 +Based on paired t-test (*** p-value < 0.001,  ** < 0.01,  * <0.05). Visits greater than 3 
standard deviations from mean visits have been Winsorized. 
  
 
As reported in Table 7, a statistically significant difference between the 
treatment group and control group were found for four of the ED visit classes. A 
statistically significant difference between the treatment group and control group 
were found for: the mean number of Emergent visits  (t = 4.0203, df = 162, p-value = 
< 0.001 percent confidence interval:  0.06773702, 0.19852064, sample estimates 
mean of the differences: 0.13); for the mean number of Emergency care need – 










Visits+ 141 119 22 15.6%   
Mean visits  0.86 (1.4) 0.73 (1.3) 0.13 15.6% *** 0.09 
Emergency care need – Primary care physician treatable 
Visits+ 54 42 12 22.2%   
Mean visits 0.33 (0.6) 0.26 (0.6) 0.07 22.2% *** 0.11 
Emergency care needed - preventable 
Visits+ 21 13 8 38.1%   
Mean visits 0.13 (0.4) 0.08 (0.3) 0.05 38.1% ** 0.12 
Emergent care needed not preventable 
Visits+ 57 52 5 8.8%   
Mean visits 0.35 (0.7) 0.32 (0.7) 0.03 8.8% P = 0.07 0.03 
Non-emergent 
Visits+ 53 56 -3 -5.7%   
Mean visits 0.33 (0.7) 0.34 (0.6) -0.02 -5.7% p = 0.32 -0.06 
Unclassifiable 
Visits+ 64 66 -2 -3.1%   
Mean visits 0.39 (0.7) 0.40 (0.8) -0.01 -3.1% p = 0.53 -0.01 
Injury 
Visits+ 21 16 5 23.8% *  




Primary care physician treatable visits (t = 3.142, df = 162, p-value = 0.002, 95 
percent confidence interval:  0.02621152, 0.11489278, sample estimates mean of the 
differences 0.07); and the mean number of Emergency care needed – preventable 
visits  (t = 2.95, df = 162, p-value = 0.004, 95 percent confidence interval:  
0.01582371 0.07988181, sample estimates mean of the differences = 0.05).  A 
statistically significant difference between the treatment group and control group was 
also found for ED visits for injuries (t = 2.2642, df = 162, p-value = 0.03, 95 percent 
confidence interval: 0.003921813, 0.057427880, sample estimates mean of the 
differences: 0.03).   
While there were significant p-values reported for the treatment group relative 
to the control group for the above mentioned ED visit types, the effect sizes were low, 
all < 0.15, suggesting very little effect of the mCare on an increased number of ED 
visits. In addition to the data reported in Table 7, robustness checks were conducted 
regarding the frequency of visit types if one of the health plans was excluded from the 
analysis sample. This procedure, which results in a non-matched sample, found no 
significant differences between the frequency of visits using a Welch’s t-test with a 
95% confidence interval. This further supports the finding that mCare did not 
significantly reduce the incidence of ED visits.  
 Analysis of the primary medical complaints from the ED visits was 
conducted.  Table 8 reports the diagnoses from the Emergent ED visits identified in 




relates. Counts is the number of times this primary diagnosis was reported in the 
claims records for the Emergent ED visits during the 21-week observational period. 
Table 8. Emergent ED visits primary diagnosis (top 10) 
 
 






R079 Chest pain, unspecified 49 23 26 
R0602 Shortness of breath 24 13 11 
R0789 Other chest pain 23 12 11 
R109 Unspecified abdominal pain 18 12 6 
I509 Heart failure, unspecified 8 4 4 
E1165 Type 2 diabetes mellitus with 
hyperglycemia 
7 4 3 
J069 Acute upper respiratory infection, 
unspecified 
7 4 3 
E11649 Type 2 diabetes mellitus with 
hypoglycemia without coma 
6 4 2 
R55 Syncope and collapse 6 4 2 
R1013 Epigastric pain 5 5 0 
 
Table 9 reports the diagnoses from the Emergency care needed - PCP treatable 
visits identified in the claims records from the ED visit.  The description is the 
medical condition to which the ICD code relates. Counts is the number of times the 
diagnosis was reported. Table 9 shows that abdominal pain, chest pains and 





Table 9. Emergency care needed – PCP treatable visits primary diagnosis  
(total codes> 1) 
 






R109 Unspecified abdominal pain 18 12 6 
J069 
Acute upper respiratory infection, 
unspecified 
7 4 3 
R072 Precordial pain 6 3 3 
R1031 Right lower quadrant pain 6 3 3 
R1013 Epigastric pain 5 5 0 
R1084 Generalized abdominal pain 5 3 2 
R1032 Left lower quadrant pain 4 2 2 
R1012 Left upper quadrant pain 3 3 0 
R0781 Pleurodynia 3 2 1 
L03311 Cellulitis of abdominal wall 2 2 0 
R1030 Lower abdominal pain, unspecified 2 2 0 
 
It is also instructive for mCare vendors to better understand the patterns of 
their users whose ED visits are considered preventable. Table10 reports the primary 
diagnoses from the preventable ED visits identified in the claims record.  Table 10 
shows that heart failure, hyperglycemia, hypoglycemia, exacerbation of asthma, and 
exacerbation of chronic obstructive pulmonary disease symptoms were the primary 





Table 10. Emergency care needed – preventable visits primary diagnosis  
(total codes > 1) 
 






I509 Heart failure, unspecified 8 4 4 
E1165 
Type 2 diabetes mellitus with 
hyperglycemia 
7 4 3 
E11649 
Type 2 diabetes mellitus with 
hypoglycemia without coma 
6 4 2 
J45901 
Unspecified asthma with (acute) 
exacerbation 
6 3 3 
J441 
Chronic obstructive pulmonary disease 
with (acute) exacerbation 
5 3 2 
J189 Pneumonia, unspecified organism 3 2 1 
R569 Unspecified convulsions 3 2 1 
 
 
 Non-emergent ED visits, which are classified as those ED visits where the 
presenting problem did not require immediate medical care within 12 hours, is 
another area to analyze in order to target improvements to ED triage processes. 
Table11 reports the primary diagnoses from the non-emergent ED visits identified in 
the claims record.  Table 11 shows that headaches, hypertension, and dizziness were 








Table 11. Non-Emergent ED visits primary diagnosis (total codes > 1) 






R51 Headache 11 6 5 
I10 Essential (primary) hypertension 11 4 7 
R42 Dizziness and giddiness 9 5 4 
M7989 Other specified soft tissue disorders 7 5 2 
R918 Other nonspecific abnormal finding of 
lung field 
6 3 3 
R112 Nausea with vomiting, unspecified 5 4 1 
M25511 Pain in right shoulder 3 2 1 
M25561 Pain in right knee 3 2 1 
M542 Cervicalgia 3 2 1 
M549 Dorsalgia (back pain), unspecified 3 2 1 
M79602 Pain in left arm 3 2 1 
M79671 Pain in right foot 2 2 0 
 
The results of the primary diagnosis analysis help illuminate specific medical 
condition areas where mCare vendors may choose to focus their processes to reach 
ED utilization goals, which is deliberated further in the Discussion chapter. 
 The analysis also examined the frequency and costs of office visits and 






Table 12. Comparison of treatment and control group office visits and inpatient 
encounters during the observational period 
 






























2.5 (5.3) 3.7 (7.5) -1.2 -48% *** -0.16 
1 sd = standard deviation 
2 Based on paired t-test (*** p-value < 0.001, ** < 0.01, * <0.05) 




As reported in Table 12, the mean number of office visits during the 
observational period is statistically significantly higher in the treatment group based 
on a paired t-test (t = 29.307, df = 162, p-value = < 000.1, 95 percent confidence 
interval: 2.322967, 2.658628, mean of the differences = 2.5).  It is also shown in 
Table 12 that the mean number of inpatient encounters during the observational 
period is statistically significantly lower in the treatment group based on a paired t-
test (t = -5.436, df = 162, p-value = < 000.1, 95 percent confidence interval: -
1.6058081, -0.7500201, mean of the differences = -1.2). The implications of these 




Table 12 also reports the mean costs of office visits and inpatient encounters 
for the treatment and control groups during the observational period. While the mean 
values of the treatment group compared to the treatment group are different, the 
differences were not significant.   
A robustness check of the findings reported in Table 12 without a plan 
included was performed. This robustness check found that there persisted a 
significant effect on office visit compliance when excluding the Charlie plan, or 
excluding the Papa plan. When excluding Bravo, the results are not significant, but 
the sample becomes much smaller.  Given the strength of the results for 3 plans, and 
two combinations of 2 plans, the office visit adherence effect of mCare is robust, as is 
an effect size of 0.44. 
RQ3: How is the response to mCare of insurance plan members with chronic 
disease related to their demographics and social support? 
As explained in the Methods chapter, linear mixed models were used to 
estimate the possible interaction effect between mCare users’ attributes, including 
their demographics (age, gender) and social support, on their diastolic and systolic 
blood pressure outcomes. The reasons for using blood pressure as a key outcome 
variable has been detailed in the Methods chapter; blood pressure regulation is a key 
cardiovascular therapeutic target and a key diabetes management therapeutic target, 




In the first analysis related to RQ3, the treatment group of 163 mCare users 
was assessed for changes in diastolic and systolic blood pressure over the five-month 
observation period in combination with their individual attributes.  (Medical device 
reading data and questionnaire data is not available for the control group of non-users 
of mCare)   
Table 13 reports the results of the linear mixed effect modeling, with an 
explanation of the technical details and results following. 
Table 13. Linear mixed model output with diastolic BP as the dependent variable  
Fixed Effects Estimates Std. Error p-value 
(Intercept) 81.70 1.19 <0.001 *** 
Month -0.30 0.10 0.003 
Has diabetes 1.14 1.13 0.315 
Male 2.26 1.04 0.030 * 
Age -0.22 0.07 0.001 ** 
Social support barriers - medium 0.62 1.25 0.622 
Social support barriers - high -0.80 1.76 0.651 
Month * Social support barriers 
medium 
-0.48 0.16 0.003 ** 
Month * Social support barriers 
high 
0.02 0.23 0.913 
Random Effects 
σ2 24.78 
τ00 UID 79.52 
ICC 0.76 






The interpretation of Table 13 is as follows.  There are 1,652 observations 
included in this analysis from 289 different mCare users.  The analysis has a Marginal 
R2 of 0.05 and a Conditional R2 of 0.77, meaning the fixed effects part of the model 
explained approximately 5 % of the total variation in the outcome. The random and 
fixed effects parts of the model explained approximately 77% of the total variation in 
the outcome. P-values are computed using lmerTest package default methods via 
ANOVA and use Satterthwaites’s methods for degrees-of-freedom (Kuznetsova, 
Brockhoff, & Christensen, 2019). Each of the factors used in this analysis are defined 
below: 
Month: The month of the observation period measured in 4-week intervals 
from baseline (week 1) through month 5. 
Has Diabetes: Whether the patient has diabetes or not (0,1). This variable is 
included since RQ3 broadened the mCare user cohort of interest beyond the diabetic 
patients of primary interest (when there was not significant power to detect effects in 
the smaller sample of 163 users). 
Male: Whether the user is male or female (0,1) 
Age: The user’s age in years 
Social support barriers – low: Social support barriers low is the default 
scenario, and these users self-reported a social barrier score between 0 and 20 out of a 




Social support barriers – medium: Grouping variable representing the users 
who self-reported a social support barrier score between 21 and 50 
Social support barriers – high: Grouping variable representing the users 
who self-reported a social support barrier score greater than 50 
Month * Social support barriers – medium: This represents the interaction 
effect between time and the group (in this case the group of users with a medium 
social support barrier score) 
Month * Social support barriers – high: This represents the interaction 
effect between time and the group (in this case the group of users with a high social 
support barrier score) 
 The model estimates at each level of social support barrier score grouping are 
provided below. At the baseline level of social support barriers (i.e. low social 
support barriers), the model equation (ŷ = predicted diastolic blood pressure (mmHg) 
is:  ŷ ≈ 126.7 + -0.82×Time + 6.52×Diabetes + 5.5×Male − 0.15×Age 
Therefore, if time increases by one month (specifically four weeks) the 
outcome will decrease by 0.30 unit on average and this difference is significant (p-
value < 0.05).  The average difference between Diabetic and non-diabetic patients is 
1.14 units (mmHg of diastolic BP, and this difference is significant (p-value = 0.03), 
which health-wise is not very meaningful.  If the average age increases by one unit 
(year) over then the outcome will decrease by -0.22 unit (mmHg) on average, and this 




benefitted slightly more in terms of their change in diastolic blood pressure. The 
mean age was 53.5 years. 
The average difference between male patients and female patients is 2.26 units 
(mmHg) of diastolic BP, and this difference is significant (p-value = 0.03), meaning 
on average males had 2.26 mmHg higher diastolic blood pressure relative to females. 
For the group with a medium level of social barriers, the estimate is: 
ŷ ≈  (81.7 + 0.62) + (-0.30 – 0.48)×Time + 1.14×Diabetes + 2.26×Male − 0.22×Age 
Therefore, for the medium social barrier group when time increases by one month 
(specifically four weeks) the outcome (mmHg diastolic BP) will decrease by 0.78 
units (mmHg) per month on average, or 3.9 units (mmHg) over a five-month period; 
and this effect is significant (p-value = 0.003). 
For the group with a high level of social barriers, the estimate is: 
ŷ ≈  (81.7 + 0.62) + (-0.30 + 0.02)×Time + 1.14×Diabetes + 2.26×Male − 0.22×Age 
For the high social barrier group, when time increases by one month (specifically four 
weeks) the outcome (mmHg diastolic BP) will decrease by 0.28 units (mmHg) per 
month on average, or 3.9 units (mmHg) over a five-month period; however, this 
effect is not significant (p = 0.913). 
Figure 10 visualizes the change in mean diastolic blood pressure at baseline, 
and at each 4-week period through month 5 for each of the three groups representing 
those members with low, medium and high social barriers.  The graph shows the 
group with the medium level of social barriers, on average, has a greater decrease in 




interval, the significance is marginal. The p-value reported estimates that there is a 
significant drop in diastolic blood pressure in the social support medium barrier group 
relative to the social support low barrier group.  
 
Figure 10. Linear mixed model: Diastolic BP mean outcomes by social support barrier 
level 
 
 The same linear mixed modeling method was applied with systolic blood 
pressure as the dependent variable. Table 14 reports these results, and is followed by 





Table 14. Linear mixed model output with systolic BP as the dependent variable  
 
Fixed Effects Estimates Std. Error p-value 
(Intercept) 126.73 1.89 <0.001*** 
Month -0.82 0.16 <0.001*** 
Has diabetes 6.52 1.80 <0.001*** 
Male 5.50 1.66 0.001** 
Age 0.15 0.10 0.156 
Social support barriers - medium 3.27 2.00 0.103 
Social support barriers - high -1.66 2.80 0.554 
Month * Social support barriers 
medium 
-0.77 0.26 0.003** 
Month * Social support barriers 
high 
-0.07 0.37 0.854 
Random Effects 
σ2 65.89 
τ00 UID 200.24 
ICC 0.75 
N UID 289 
 
 
The interpretation of Table 14 is as follows.  There are 1,652 observations 
included in this analysis from 289 different mCare users.  The analysis has a Marginal 
R2 of 0.07 and a Conditional R2 of 0.77, meaning the fixed effects part of the model 
explained approximately 7% of the total variation in the outcome. The random and 
fixed effects parts of the model explained approximately 77% of the total variation in 
the outcome. P-values are computed using lmerTest package default methods via 





The variables used in Table 14 are the same as those used (and described) in 
Table 13, with the exception of systolic blood pressure replacing diastolic blood 
pressure as the dependent variable. 
 The model estimates at each level of social support barrier score grouping are 
provided below. At the baseline level of social support barriers (i.e. low social 
support barriers), the model equation (ŷ = predicted systolic blood pressure (mmHg)) 
is:  ŷ ≈ 126.7 + -0.82×Time + 6.52×Diabetes + 5.5×Male + 0.15×Age 
Therefore, if time increases by one month (specifically four weeks) the 
outcome will decrease by 0.82 unit (mmHg) on average and this difference is 
significant (p < 0.05).  The average difference between Diabetic and non-diabetic 
patients is 6.52 units (mmHg of systolic BP), and this difference is significant (p-
value < 0.001).  If the average age increases by one unit (year), then the outcome will 
increase by 0.15 unit (mmHg) on average, and this effect is not significant (p-value = 
0.156). 
The average difference between male patients and female patients is 5.5 units 
(mmHg of systolic BP), and this difference is significant (p-value = 0.001). 
For the group with a medium level of social barriers, the estimate is: 
ŷ ≈ (126.7+3.27) + (-0.82-0.77)×Time + 6.52×Diabetes + 5.5×Male − 0.15×Age 
Therefore, for the medium social barrier group, when time increases by one month 
(specifically four weeks) the outcome (mmHg systolic BP) will decrease by 1.59 
units (mmHg) per month on average, or 7.95 units (mmHg) over a five-month period, 




For the group with a high level of social support barriers, the estimate is: 
ŷ ≈ (126.7-1.66) + (-0.82 - 0.07)×Time + 6.52×Diabetes + 5.5×Male + 0.15×Age 
For the high social barrier group, when time increases by one month (specifically four 
weeks) the outcome (mmHg diastolic BP) will decrease by 0.89 units (mmHg) per 
month on average, or 4.45 units (mmHg) over a five-month period; however, this 
effect is not significant (p = 0.854). 
 Figure 11 graphs the mean value of systolic blood pressure at baseline and 
each of the four-week intervals. The whiskers represent the 95% confidence intervals. 
The graph show that the slope of the medium group is slightly steeper than the other 
two groups, meaning on average, the systolic blood pressure rate of decrease was 





Figure 11. Linear mixed model systolic BP mean outcomes by social support barrier 
level 
 
Further interpretation and sensemaking regarding these results are discussed 
in the next chapter, including potential limitations to generalizability and directions 






Chapter 5: Discussion, Conclusions and Future Directions 
5a. Discussion 
This dissertation study aimed to reveal patterns regarding the use and impact 
of an mCare system, especially as it relates to use by health plan members with 
diabetes.  Specifically, the analysis reported in this dissertation sought to understand 
mCare’s influences on health outcomes and healthcare utilization.  
RQ1:  What types of health benefits does mCare provide to insurance 
plan members with type 2 diabetes? 
mCare aims to improve patient self-management of chronic disease by helping 
patients better sense, measure and understand their specific risk factors. In the case of 
reduction of cardiovascular risk factors through more well-regulated blood pressure, 
over the five-month observational period the use of mCare achieved this aim for the 
majority of it users, and on average across the mCare users.   
On the other hand, decreases in weight and glucose were not reported at a 
significant level during the 5-month observational period. 
The specific mechanisms for the improvements in blood pressure are less 
clear. It may be that medication adherence improved from the monitoring, the 
individuals adjusted their diets, or they reduced stress, or a combination thereof. The 
health coaches seek to identify the specific barriers patients face and educate and 




RQ2:  What types of utilization and cost implications does mCare have 
for insurance plans and their members with diabetes? 
The analysis of ED utilization found that the use of mCare by the treatment 
group did not significantly reduce the use of the ED compared to the control group. 
The analysis reviewed the frequency of several classes of ED visits and the 
complaints (diagnoses) for those visits. The treatment group used the ED at a small, 
but significantly higher rate, than the control group for emergent ED visits, 
Emergency care need – Primary care physician treatable visits, and Emergency care 
needed – preventable ED visits, albeit with very small effect sizes ( < 0.15). 
This pattern of ED visits suggests that mCare processes regarding the triage of 
problems to non-ED sites of care could be better constructed. Many of the complaints 
the members using mCare presented with at the ED are classified as treatable in non-
acute care settings.  The practice of medicine in the United States has developed a 
very low tolerance for risk, which may help explain the use of the ED at the first sign 
of pain even if the pain or other problem is related to a problem that does not require 
ED use.  On the one hand, the fact that the treatment group members were more 
activated to respond to particularly dangerous health conditions is positive; on the 
other hand, the member, coach and decision support should be better able to discern 
that the issue is able to be treated at the primary care physician’s office or is non-
emergent. 
One of the primary goals of mCare is to reduce and appropriately triage 




was not observed in this study.  Particularly noteworthy was that the ED visit type 
comparison between the treatment and control group of the Emergency care needed - 
primary care physician treatable visit type, and Emergency care needed - 
preventable/avoidable visit type, did not show marked improvements. 
The Emergency care needed - preventable/avoidable visit type means that ED 
care was required based on the complaint or procedures performed/resources used, 
but the emergent nature of the condition was potentially preventable/avoidable if 
timely and effective ambulatory care had been received during the episode of illness 
(e.g., the flare-ups of asthma, diabetes, congestive heart failure, etc.). The Emergency 
care needed - preventable/avoidable visit type of the treatment and control groups in 
this study were frequently related to heart failure, hyperglycemia, hypoglycemia and 
pulmonary issues (such as asthma and COPD). The analysis revealed that the 
hyperglycemic events in the control group were more common than that of the 
treatment group, indicating that the avoidance of hyperglycemia in particular is an 
area in which mCare may be showing progress. The study results reinforce that 
mCare vendors should focus on hypertension management and hyperglycemia 
avoidance as key components of their therapeutic goals. 
The Emergency care needed - primary care physician treatable visit type 
means that based on information in the record, treatment was required within 12 
hours, but care could have been provided effectively and safely in a primary care 
setting.  The vast majority of these visits witnessed during this study were related to 




mCare could do a better job at gauging the causes of pains, assuaging pain and 
triaging users to sites of care more appropriately. 
There were also a significant number of non-emergent ED visits reported by 
the treatment group at rates similar to the control group. These visits were frequently 
related to headaches, hypertension, dizziness, swelling (soft tissue disorders), and 
pulmonary issues. These results suggest mCare vendors can do a better job triaging 
cases that are not true emergencies. Among these results, there were fewer 
hypertension ED cases in the treatment group versus the control group, suggesting 
mCare may be helping with better hypertension management. 
What may be driving the ED use of the treatment group? Prior work (Painter, 
Borba, Hynes, Mays, & Glanz, 2008) suggests that when individuals with chronic 
disease become more aware of the severity of their condition, the possible 
consequences, and their ability to do something about it, then they, on average, 
become more activated healthcare consumers.  Prior work in the health information 
behavior domain has also shown that there is a sizable population of individuals that 
actively avoid health information and services, and that the tendency to engage in 
avoidance is greater in individuals with lower health literacy and greater 
socioeconomic disadvantage (Case et al., 2005).  This describes the population of 
interest in this study, which are members of Medicaid managed care plans.  
This study also examined the differences in usage of other sites of care.  The 
results suggest an increased activation of patients within the treatment group. mCare 




inpatient hospital encounter.  These results indicate mCare can be useful in helping 
individuals maintain their continuity of care and visit their doctors. 
The findings regarding health effects revealed a small, but clinically and 
statistically significant, impact on cardiovascular health.  While an average 3-point 
diastolic drop may not seem substantial, a meta-analysis that comprised over 460,000 
people reported that for a BP reduction of 10 mmHg systolic or 5 mmHg diastolic, 
there was a 22% decrease in coronary heart disease events and a 41% decline in 
stroke (Mensah et al., 2017). 
An interesting finding was that there were differences in the degree of benefit 
received in terms of blood pressure management from the mCare users based on their 
social barriers These results provide supporting evidence of the role of social barriers 
in moderating the potential effectiveness of mCare interventions.  One reason that this 
finding may be expected, is that those individuals with existing social support through 
family, friends or other personal relationships and networks may have less need for 
the social support that a health coach provides as part of an mCare system. 
Interestingly, it was the group with a moderate amount of social support that had a 
significant benefit, suggesting that those individuals with the most challenging social 
situations may need extra supports.  Furthermore, given the complex landscape of 
health behavior theory, quantifying factors such as social support that influence the 
impact of mobile health systems can lead to more complete health behavior models 




As the healthcare industry seeks to unlock the secret to precision tailoring of 
behavioral interventions, this study’s findings indicate that focusing particularly on 
those individuals who report a moderate gap in social support, the return on 
investment may potentially increase.  This finding does not advocate that population 
health managers ignore those individuals with very low or very high social support 
barriers, but rather, when designing program components, one must consider the 
individual nuances and find targeted ways to better engage particular patient 
subgroups. 
The empirical evidence of the importance of creating social support and 
conducive environments for disease self-management are evident.  How can the 
health system possibly expect someone to regularly check their blood sugar, adjust 
their diet, purchase new medication, stand on an internet-connected scale, and 
communicate back to their care providers through an app if they don’t have a stable 
and supportive life situation?  The addition of social supports such as mCare offers 
may help, and this study’s results suggest that the health coach can positively impact 







This dissertation sought to answer how an mCare system may impact health 
outcomes and healthcare utilization for mCare users and to uncover potential 
variation in the effects of mCare in relation to the individual differences of the mCare 
end users.  
This study’s conclusions include the following. mCare has a significant effect 
on the cardiovascular health of the users as measured by their diastolic and systolic 
blood pressure, whereas the effect on weight and average glucose was less significant. 
mCare has a significant effect on the use of office visits by its users, resulting in 
greater continuity of care, and perhaps contributing to fewer inpatient visits, on 
average.  mCare did not reduce emergency department visits or triage emergent 
problems that are considered treatable at the primary care office, or non-emergent 
problems relative to non-users in the first five months of use. mCare did not reduce 
preventable ED visits in the first five months of use, relative to the control group, 
suggesting there may be a longer time horizon needed to change health trajectories, 
on average. mCare users had significantly less frequent inpatient encounters, 1.2 
fewer encounters on average, during the five-month observational period. Those 
mCare users who had a moderate degree of social support in their lives on average 
benefitted from the intervention in terms of improved cardiovascular health outcomes 
more so than users with a lot or no social support. This benefit equated, on average, to 
a 2.4 mmHg drop (2.9%) in diastolic blood pressure and a 3.9 mmHg (3.1%) drop in 




realized significantly greater benefit from the mCare intervention than men in terms 
of a reduction of blood pressure. 
Implications for practice, design and theory 
For designers, this study identified specific targets of mCare use where mCare 
is showing success (e.g. office visits), and other areas (e.g. emergency department 
triage) where improved information system and process design is needed.  mCare 
designers and vendors can focus their attention accordingly. For example, by 
designing better pain triage mechanisms and diagnostics, presumably an improvement 
in the rate of unnecessary and primary care treatable ED visits can be achieved. 
Additional training for health coaches, as well as training and development of 
machine intelligence algorithms to better triage patient problems to appropriate sites 
of care, are needed.  mCare designers should seek to better gauge the severity of pain, 
and develop new sensor technologies to better assess emergent issues, especially 
abdominal pain, based on biomarkers or other physiological signals. mCare vendors 
should focus on refining their processes to enable better glucose management that 
avoids exacerbations, and to predict exacerbations earlier so that they can be avoided.  
For medical conditions in which getting patients to regular office visits is a challenge, 
but these visits offer significant therapeutic and/or cost-effective benefit, mCare may 
be a successful strategy for achieving visit adherence goals. 
Most health behavior theories were constructed at a time when mobile 
applications and connected sensors were not readily available; therefore the mental 




world works today. The theoretical constructs purported to influence health behavior 
and intervention design such as an individual’s health literacy, beliefs, and 
capabilities likely still influence health behavior; however the mechanisms of how 
these constructs can be influenced in a mobile-digital age are evolving. In the current 
environment, healthcare professionals have an expanded arsenal of tools to equip 
patients; it is important to understand how the individual factors of each patient may 
translate into successful outcomes from the use of these tools.   This dissertation 
helped contribute to a more nuanced understanding of the effects of mCare.   
This study illuminated differences in the effects of mCare based on one’s 
social support environment.  It may not be surprising that simply providing a person 
with chronic disease an mCare solution will not be equally successful across a 
population. This dissertation uncovered, interestingly, that those with a moderate 
degree of social support were more likely to achieve benefit, on average, relative to 
those with high or low social support in their lives. This dissertation corroborates that 
an application that uses a one-size-fits-all approach that doesn’t account for the 
unique social support situations of individual, may not be optimally engaging its 
users. 
5c. Limitations 
This research yielded insights regarding the impacts of mCare usage on health 




limitations to the generalizability and interpretation of the results that should be 
considered.  
The strength of evidence in the study of a health intervention using an 
observational cohort is less than that of a randomized controlled trial.  However, 
observational, well-controlled studies can have good validity and a matched sample is 
a feasible approach (Thiese, 2014).   A limitation is that the treatment and control 
group were not exactly matched by health plan. Rather, members were matched on 
the attributes that are most relevant to similarity in disease burden and demographics, 
as an exact matching by plan would yield a poorly matched control group. 
The duration of the study is 21 weeks, a relatively short period in the context 
of the life of an individual who has a chronic disease.  Yet, the results provide real-
world evidence of what happens in the five months after the start of an mCare 
regimen, and the data is able to provide statistically significant and interpretable 
results. While the effect sizes may be small, in the context of the vast network of 
factors that may drive health outcomes and use, it is nonetheless instructive.  This 
study design has the strength of multiple data types, covering the timeframe before, 
during, and at the completion of five months of mCare use.  While changes in blood 
pressure and healthcare utilization over the course of the study period cannot be fully 
attributed to the specific mechanisms of intervention (the coach, drug adherence, 




5d. Future Directions 
Future work should examine the long-term outcomes of mCare. These longer 
term views may integrate additional economic measures such as Quality of Life-
Adjusted Years (QALY’s), which is a measure of disease burden, incorporating both 
the quality and the quantity of life lived (Ryen & Svensson, 2015).   
Another limitation of this study is that we do not know the exact mCare 
features and functions that the health plan members used, given the dataset of this 
study.  Future work may explore the specific features used and their relationship to 
the mCare outcomes observed.  In addition to evaluating feature use, given the 
heterogeneity of users, testing of specific messaging and adaptation strategies for 
system interaction would be useful.  There are emerging methods and systems (e.g. 
JITAI’s) that support the real-time adaptability of interventions based on a variety of 
user data (e.g. psychology, mood, health trajectory, etc.), which is an exciting area for 
future study. 
Future work may include a prospective randomized controlled trial whereby 
individuals with social barriers can be appropriately randomized to allow for further 
validation of the findings.  mCare vendors/researchers should experiment with 
adjusting the level of social support based on the target user’s unique situation.   
In preparation for such a trial, further validation of the social support scales is 
recommended.  The scales used in the mCare questionnaire for this study have not 
been validated. However, they have simplicity in structure and design, which allows 




particular for social support, tailoring them to the mCare context may benefit future 
practical use and related health services research. 
The study results suggest there is not a highly accurate method to triage pain 
and decide whether the pain requires emergency intervention. Biomedical sensor 
designers should seek to provide sensors and decision-support that can more 
accurately identify when situations are truly an emergency. 
Future work may also explore incentives and other mechanisms that may be 
used to triage chronic disease patients to the most fitting healthcare delivery 
locations.  Finally, research into the specific coaching strategies being employed in 
relation to the chronic disease member’s attributes and how it may differentially 
impact mCare user outcomes could yield fruitful future intervention designs that are 
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